Beauty Farm Medical and Health Industry Inc. (2373) announced on October 20, 2025, that 70,000 shares were repurchased on the market at an average price of approximately HK$31.56 per share, with a total consideration of about HK$2,209,470. From October 15, 2025, to the date of this announcement, the cumulative repurchased shares reached 210,000, totaling around HK$6,858,180.

According to the board of directors, the repurchase was approved under the general mandate granted at the annual general meeting on June 27, 2025, authorizing up to 10% of the issued shares (23,579,556 shares). The board noted that the trading price of the shares does not reflect their intrinsic value or business prospects and emphasized confidence in the long-term value of the enterprise. However, shareholders and potential investors were cautioned that the repurchase remains subject to market conditions, with no assurance regarding timing, quantity, or price.